Liver function damage caused by hyperthyroidism itself includes symptoms such as jaundice, elevated liver enzymes, anorexia, aversion to oil, diarrhea, and other digestive system symptoms. Due to the lack of specific manifestations, it should be distinguished from viral hepatitis and liver damage caused by antithyroid drugs, as the mechanisms and treatment methods of these three types of liver damage are different. Therefore, early and clear diagnosis is particularly important.
1. The following are some differences between hyperthyroidism accompanied by hepatitis and liver damage caused by hyperthyroidism:
1. Irrelevant to the severity of hyperthyroidism.
2. Obvious symptoms of hepatitis such as anorexia and aversion to oil in the digestive system.
3. Positive markers of hepatitis infection.
4. Ineffectiveness of antithyroid treatment, etc.
Secondly, the diagnosis of antithyroid drug-induced liver damage is usually made by exclusion.
1. Clinical laboratory tests show evidence of liver damage.
2. Temporal association between medication and liver damage, that is, liver damage occurs after medication.
3. No serological evidence of hepatitis virus infection or autoimmune hepatitis.
4. No evidence of chronic liver disease.
5. No other known hepatotoxic drugs were used simultaneously.
6. Liver function improves or recovers after discontinuation of medication.
7. Pathology shows mononuclear cells and lymphocytes infiltrating the liver lobules.
8. Repeated use of the same drug can cause liver damage again.
It is generally believed that liver damage caused by antithyroid drugs is more common within the first 3 months of medication. The liver damage caused by PTU is mainly characterized by varying degrees of liver cell necrosis, while the liver damage caused by MMI is mainly characterized by intrahepatic cholestasis, that is, cholestasis in liver cells and/or bile ducts. The former is mainly manifested by an increase in transaminases, while the latter is mainly manifested by an increase in bilirubin.